Schedule 13D ownership disclosure

AUTOLUS THERAPEUTICS LTD

Security class unavailable · CUSIP: 05280R100

Event date: 2022-09-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,612,275
Percent of class
16.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-062213
Form type
SC 13D/A
Filer
Autolus Therapeutics plc
CIK
CIK 1730463
Filed
Oct 05, 2022
Reporting period
Sep 23, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub